Cargando…

The Mathematical and Computational Sciences Special Interest Group of the International Society of Pharmacometrics

Detalles Bibliográficos
Autor principal:	Moore, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656932/ https://www.ncbi.nlm.nih.gov/pubmed/30983157 http://dx.doi.org/10.1002/psp4.12410

Ejemplares similares

Pharmacometrics: Focus on the Patient
por: Dumitrescu, T Pene, et al.
Publicado: (2015)

Opinion: The Pharmacometrics of Infectious Disease
por: Davies, G R, et al.
Publicado: (2013)

Pharmacometrics in Australasia—Twenty Years of Population Approach Group of Australia and New Zealand
por: Hennig, Stefanie, et al.
Publicado: (2019)

Time to Expect More From Pharmacometrics
por: Barrett, Jeffrey S.
Publicado: (2020)

Perspective on the State of Pharmacometrics and Systems Pharmacology Integration
por: Trame, Mirjam N., et al.
Publicado: (2018)

Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?
por: Chaturvedula, Ayyappa, et al.
Publicado: (2019)

Meeting Report: PMDA Public Workshop on Pharmacometrics at Japan
por: Kijima, Shinichi, et al.
Publicado: (2020)

Response to “Pharmacometric Approach to Evaluate Drug Dosing Adherence”
por: Ding, Junjie, et al.
Publicado: (2020)

R and nlmixr as a gateway between statistics and pharmacometrics
por: Fidler, Matthew, et al.
Publicado: (2021)

Where Do PBPK Models Stand in Pharmacometrics and Systems Pharmacology?
por: Jamei, Masoud
Publicado: (2020)

Variable or variate? A conundrum in pharmacometrics exposure–response models
por: Grisic, Ana‐Marija, et al.
Publicado: (2022)

Barriers to global pharmacometrics: educational challenges and opportunities across the globe
por: Michelet, Robin, et al.
Publicado: (2023)

The International Society of Pharmacovigilance Vaccines Special Interest Group: Challenges and Opportunities
por: Chandler, Rebecca E.
Publicado: (2022)

Pharmacometrics: Opportunity for Reducing Disease Burden in the Developing World: The Case of Africa
por: Pillai, G, et al.
Publicado: (2013)

Role of pharmacometrics and systems pharmacology in facilitating efficient dose optimization in oncology
por: Jayachandran, Priya, et al.
Publicado: (2023)

The Asian Pharmacometrics Network: The historical background, establishment, objectives and roles, and recent activities
por: Kaibara, Atsunori, et al.
Publicado: (2022)

The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance
por: Yue, Qun-Ying
Publicado: (2021)

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development
por: Swat, MJ, et al.
Publicado: (2015)

Approaching Pharmacometrics as a Paleontologist Would: Recovering the Links Between Drugs and the Body Through Reconstruction
por: Craig, M, et al.
Publicado: (2016)

Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches
por: Schmidt, Stephan, et al.
Publicado: (2019)

Dr. Hartmut Derendorf, PhD, a world‐renowned expert in pharmacokinetics and pharmacometrics (1953–2020)
por: Sinha, Vikram, et al.
Publicado: (2021)

Applied Pharmacometrics (AAPS Advances in the Pharmaceutical Sciences Series)
por: Meibohm, Bernd
Publicado: (2015)

COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper
por: Farhoudian, Ali, et al.
Publicado: (2020)

Iberoamerican Pharmacometrics Network Congress 2018 Report: Fostering Modeling and Simulation Approaches for Drug Development and Regulatory and Clinical Applications in Latin America
por: Ibarra, Manuel, et al.
Publicado: (2019)

Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance
por: Bahri, Priya, et al.
Publicado: (2023)

Metaheuristics for pharmacometrics
por: Kim, Seongho, et al.
Publicado: (2021)

1st Meeting of the Special Interest Group in Computational Phonology
Publicado: (1994)

Meeting of the Special Interest Group on Parsing : Punctuation in Computational Linguistics
Publicado: (1996)

Considering a Society of Environmental Health Science
por: Schwartz, David A.
Publicado: (2006)

Realigning science, society and policy in uncertain times
por: Mehta, Goverdhan, et al.
Publicado: (2020)

Earth 2020: Science, society, and sustainability in the Anthropocene
por: Tortell, Philippe D.
Publicado: (2020)

Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members
por: Mentré, F, et al.
Publicado: (2013)

Optimized Alectinib Dose Regimen for Treatment of Patients With ALK‐Positive Non‐Small Cell Lung Cancer Based on Robust Pharmacometric Analyses and Clinical Evidence
por: Frey, Nicolas, et al.
Publicado: (2021)

International Symposium on Mathematical Foundations of Computer Science
por: Collective
Publicado: (1995)

3rd Meeting of the ACL Special Interest Group in Computational Phonology
Publicado: (1997)

Pharmacometrics and/or Systems Pharmacology
por: van der Graaf, Piet H.
Publicado: (2019)

Commentary on Pharmacometrics for Immunotherapy
por: Garrido, MJ, et al.
Publicado: (2017)

The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics
por: van Hasselt, J G Coen, et al.
Publicado: (2012)

Why Having a (Nonfinancial) Interest Is Not a Conflict of Interest
por: Bero, Lisa A., et al.
Publicado: (2016)

The Lasker~Koshland Special Achievement Award in Medical Science awarded to Piet Borst
por: Nusse, Roel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4ct9tv231c8r990kq1smnintkl